GIS and OBD, a wholly owned subsidiary of Oxford Biodynamics Limited, have signed a Collaboration Agreement to jointly develop the EpiSwitchTM technology to create a focused EpiSwitchTM epigenetic signature to compare IPSCS, ESCS and Progenitor cell lines.